Cargando…

Nomogram Predicting Survival to Assist Decision-Making of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma

The survival benefit of metastasectomy (MSX) in patients with metastatic renal cell carcinoma (mRCC) remains unclear. A reliable model to predict an individuals’ risk of cancer-specific mortality (CSM) and to identify optimal candidates for MSX is needed. We identified 2,911 mRCC patients who underw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Kan, Liu, Zhihong, Shao, Yanxiang, Li, Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793951/ https://www.ncbi.nlm.nih.gov/pubmed/33425741 http://dx.doi.org/10.3389/fonc.2020.592243

Ejemplares similares

Nomogram predicting survival to assist decision-making of radical prostatectomy in patients with metastatic prostate cancer
por: Wu, Kan, et al.
Publicado: (2021)

A Retrospective Analysis of the Impact of Metastasectomy on Prognostic Survival According to Metastatic Organs in Patients With Metastatic Renal Cell Carcinoma
por: Kim, Sung Han, et al.
Publicado: (2019)

Long-term survival of a patient with pulmonary metastatic urothelial carcinoma following metastasectomy
por: Hasebe, Kenichi, et al.
Publicado: (2018)

A New Online Dynamic Nomogram: Construction and Validation of an Assistant Decision-Making Model for Laryngeal Squamous Cell Carcinoma
por: Liu, Yuchen, et al.
Publicado: (2022)

Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient Survival
por: Ma, Lidi, et al.
Publicado: (2022)

Development and validation of nomograms predicting postoperative survival in patients with chromophobe renal cell carcinoma
por: Li, Shuaishuai, et al.
Publicado: (2022)

Integrating metastasectomy and stereotactic radiosurgery in the treatment of metastatic renal cell carcinoma
por: Bex, Axel
Publicado: (2013)

Nine-year survival after iterative metastasectomies for renal cell carcinoma
por: de Oliveira, Tiago Ribeiro, et al.
Publicado: (2019)

Survival benefit of pancreatic metastasectomy of clear cell renal cell carcinoma
por: Fang, Yuan, et al.
Publicado: (2019)

Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable
por: Vogl, U M, et al.
Publicado: (2006)

The Significance of Metastasectomy in Patients with Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy
por: Yu, Xiaoteng, et al.
Publicado: (2015)

A Nomogram Based on Serum Biomarkers and Clinical Characteristics to Predict Survival in Patients With Non-Metastatic Nasopharyngeal Carcinoma
por: Li, Qing-Jie, et al.
Publicado: (2020)

Development and validation of a prognostic nomogram for predicting cancer-specific survival in patients with metastatic clear cell renal carcinoma: A study based on SEER database
por: Huang, Guangyi, et al.
Publicado: (2022)

Survival of Patients With Metastatic Rectum Cancer Who Underwent Metastasectomy Following Conversion Chemotherapy Sans Pelvic Radiotherapy: A Turkish Oncology Group Study
por: Almuradova, Elvina, et al.
Publicado: (2023)

Novel Nomograms Individually Predicting Overall Survival of Non-metastatic Colon Cancer Patients
por: Pei, Jun-Peng, et al.
Publicado: (2020)

Cytoreductive Nephrectomy and Nephrectomy/Complete Metastasectomy for Metastatic Renal Cancer
por: Russo, Paul, et al.
Publicado: (2007)

Artificial intelligence-based prediction of overall survival in metastatic renal cell carcinoma
por: Barkan, Ella, et al.
Publicado: (2023)

Role of metastasectomy in the management of renal cell carcinoma
por: Mikhail, Mark, et al.
Publicado: (2022)

Survival after Metastasectomy for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis
por: Patel, Vaibhav, et al.
Publicado: (2017)

Role of Metastasectomy on Overall Survival of Patients with Metastatic Gastric Cancer
por: Yang, Seung Wook, et al.
Publicado: (2013)

Development of a Nomogram to Predict Disease-Specific Survival for Patients After Resection of a Non-Metastatic Adenocarcinoma of the Pancreatic Body and Tail
por: Zou, Yiping, et al.
Publicado: (2020)

A Nomogram Predicting the Progression-Free Survival of Nonmetastatic Renal Cell Carcinoma Patients With Venous Thrombus After Surgery
por: Zhang, Yu, et al.
Publicado: (2022)

Radiomics Nomogram in Assisting Lymphadenectomy Decisions by Predicting Lymph Node Metastasis in Early-Stage Endometrial Cancer
por: Liu, Xue-Fei, et al.
Publicado: (2022)

Pulmonary metastasectomy in colorectal cancer: a prospective study of demography and clinical characteristics of 543 patients in the Spanish colorectal metastasectomy registry (GECMP-CCR)
por: Embún, R, et al.
Publicado: (2013)

A 15-Gene Signature and Prognostic Nomogram for Predicting Overall Survival in Non-Distant Metastatic Oral Tongue Squamous Cell Carcinoma
por: Liu, Muyuan, et al.
Publicado: (2021)

Development and validation of a nomogram to evaluate the therapeutic effects of second-line axitinib in patients with metastatic renal cell carcinoma
por: Lin, Dengqiang, et al.
Publicado: (2023)

Establishment and validation of a nomogram to select patients with metastatic sarcomatoid renal cell carcinoma suitable for cytoreductive radical nephrectomy
por: Zhou, Yulin, et al.
Publicado: (2023)

A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma
por: Zhang, Shu-Wen, et al.
Publicado: (2022)

Twelve-year survival after multiple recurrences and repeated metastasectomies for renal cell Carcinoma
por: Wang, Jue, et al.
Publicado: (2011)

Metastasectomy could not improve the survival of metastatic urothelial carcinoma: evidence from a meta-analysis
por: Xing, Qianwei, et al.
Publicado: (2020)

The Nomogram Model Predicting Overall Survival and Guiding Clinical Decision in Patients With Glioblastoma Based on the SEER Database
por: Li, Hongjian, et al.
Publicado: (2020)

A Simple-to-Use Nomogram for Predicting the Survival of Early Hepatocellular Carcinoma Patients
por: Chen, Si-Hai, et al.
Publicado: (2019)

Development and validation of nomograms to predict survival in patients with invasive micropapillary carcinoma of the breast
por: Cheng, Yixin, et al.
Publicado: (2023)

Development and Validation of Nomograms to Predict Overall Survival and Cancer-Specific Survival in Patients With Pancreatic Adenosquamous Carcinoma
por: Yang, Zhen, et al.
Publicado: (2022)

Prognostic nomogram that predicts progression-free survival and overall survival of patients with ovarian clear cell carcinoma
por: Li, Jiayi, et al.
Publicado: (2022)

Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation
por: Gu, Cheng-Yuan, et al.
Publicado: (2021)

Impact of healthcare inequities on survival in Mexican patients with metastatic renal cell carcinoma
por: Bourlon, Maria T., et al.
Publicado: (2023)

Modified Predictive Model and Nomogram by Incorporating Prebiopsy Biparametric Magnetic Resonance Imaging With Clinical Indicators for Prostate Biopsy Decision Making
por: Pan, Jin-feng, et al.
Publicado: (2021)

A novel nomogram for decision-making assistance on exemption of axillary lymph node dissection in T1–2 breast cancer with only one sentinel lymph node metastasis
por: Liu, Lei, et al.
Publicado: (2022)

A Novel Nomogram for Prediction and Evaluation of Lymphatic Metastasis in Patients With Renal Cell Carcinoma
por: Li, Wenle, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g3u85rrt6v51dut2ln0ih8kj9j